CD4 and neoplasm: Enhancing immunity (CD4, CD8), reduced serum TGF-β1 and CD4 + CD25 + Foxp3 + Treg (regulatory T cells) proportion in PBMC (peripheral blood mononuclear cell), spleen lymphocytes, and TIL (tumor-infiltrating lymphocytes)